PortfoliosLab logoPortfoliosLab logo
Wellgistics Health, Inc (WGRX)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US9495031067
IPO Date
Feb 21, 2025

Highlights

Market Cap
$6.84M
Enterprise Value
$42.84M
EPS (TTM)
-$1.47
Total Revenue (TTM)
$23.34M
Gross Profit (TTM)
-$6.43M
EBITDA (TTM)
-$90.54M
Year Range
$0.10 - $7.04
ROA (TTM)
-332.49%
ROE (TTM)
813.59%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Wellgistics Health, Inc

Often compared with WGRX:
WGRX vs. NEUP

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Wellgistics Health, Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Wellgistics Health, Inc (WGRX) has returned -75.87% so far this year and -97.77% over the past 12 months.


Wellgistics Health, Inc

1D
-3.60%
1M
-59.67%
YTD
-75.87%
6M
-89.13%
1Y
-97.77%
3Y*
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Feb 21, 2025, WGRX's average daily return is -0.54%, while the average monthly return is -17.34%.

Historically, 21% of months were positive and 79% were negative. The best month was Mar 2025 with a return of +60.0%, while the worst month was Mar 2026 at -59.7%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 7 months.

On a daily basis, WGRX closed higher 36% of trading days. The best single day was Oct 24, 2025 with a return of +185.4%, while the worst single day was May 8, 2025 at -30.6%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-10.24%-33.35%-59.67%-75.87%
2025-29.13%60.00%0.46%-53.69%-51.81%-10.40%41.72%-27.88%-21.18%-14.17%-33.43%-89.51%

Benchmark Metrics

Wellgistics Health, Inc has an annualized alpha of -77.66%, beta of 1.44, and R² of 0.01 versus S&P 500 Index. Calculated based on daily prices since February 24, 2025.

  • This stock participated in 396.82% of S&P 500 Index downside but only -243.99% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.01 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-77.66%
Beta
1.44
0.01
Upside Capture
-243.99%
Downside Capture
396.82%

Return for Risk

Risk / Return Rank

WGRX ranks 10 for risk / return — in the bottom 10% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


WGRX Risk / Return Rank: 1010
Overall Rank
WGRX Sharpe Ratio Rank: 2323
Sharpe Ratio Rank
WGRX Sortino Ratio Rank: 44
Sortino Ratio Rank
WGRX Omega Ratio Rank: 88
Omega Ratio Rank
WGRX Calmar Ratio Rank: 11
Calmar Ratio Rank
WGRX Martin Ratio Rank: 1616
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Wellgistics Health, Inc (WGRX) and compare them to a chosen benchmark (S&P 500 Index).


WGRXBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.40

0.90

-1.29

Sortino ratio

Return per unit of downside risk

-1.63

1.39

-3.02

Omega ratio

Gain probability vs. loss probability

0.83

1.21

-0.38

Calmar ratio

Return relative to maximum drawdown

-1.00

1.40

-2.39

Martin ratio

Return relative to average drawdown

-1.24

6.61

-7.85

Explore WGRX risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Wellgistics Health, Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Wellgistics Health, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Wellgistics Health, Inc was 98.06%, occurring on Mar 31, 2026. The portfolio has not yet recovered.

The current Wellgistics Health, Inc drawdown is 98.06%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.06%Mar 24, 2025257Mar 31, 2026
-33.33%Feb 24, 202512Mar 11, 20255Mar 18, 202517
-0.5%Mar 19, 20251Mar 19, 20251Mar 20, 20252

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Wellgistics Health, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Wellgistics Health, Inc is priced in the market compared to other companies in the Pharmaceutical Retailers industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for WGRX relative to other companies in the Pharmaceutical Retailers industry. Currently, WGRX has a P/S ratio of 0.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items